Join
Live feed
·
INSIDERFilingvia Quantisnow
Marinus Pharmaceuticals Inc. logo

SEC Form 4: Austin Charles sold $6,964 worth of shares (1,073 units at $6.49) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 5,277 units (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
MRNS· Marinus Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRNS (Marinus Pharmaceuticals Inc.) and more on Quantisnow.